University of Patras
Ο ρόλος του επιθηλιακού πυρηνικού παράγοντα-κΒ στη χημική και γενετική καρκινογένεση πνεύμονα
Abstract
dc:descriptionAlthough oncogenic activation of NF-κΒ has been identified in various tumors, the NF-κΒ-activating kinases (IKKs) responsible for this are elusive. Here we report an actionable requirement for IKKα in KRAS-mutant lung adenocarcinomas induced by the carcinogen urethane and by respiratory epithelial expression of oncogenic KRASG12D. For this, we mapped NF-κΒ activation in the lungs during chemical and genetic adenocarcinoma development and found two distinct early and late activation phases, which were characterized by nuclear translocation of RelB, ΙκΒβ, and /or IKKα in tumor-initiated cells. We further used conditional IKKα and ΙΚΚβ-deleted mice to identify that IKKα is a cardinal tumor promoter in KRAS-mutant lung adenocarcinoma. We also co-expressed IKKα or ΙΚΚβ with wild-type or mutant KRAS in benign cells, and show that IKKα cooperates with mutant KRAS for tumor induction. Finally, we show that IKKα is highly expressed in human lung adenocarcinomas, and that a dual IKKα/β inhibitor delivers superior effects against KRAS-mutant lung adenocarcinoma compared with a specific IKKβ inhibitor. These results position IKKα as a target against KRAS-mutant lung adenocarcinoma and provide proof-of-principle data for future targeting of KRAS-IKKα addiction in the disease.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Vreka, Malamati
- Βρέκα, Μαλαματή
Subjects
dc:subject × 6Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42091